e-learning
resources
Munich 2006
Sunday 03.09.2006
COPD – inflammation/miscellaneous
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The cost analysis of our COPD patients
G. Balci, S. Dereli, L. Usta, E. Tellioglu, Y. Vatansever, R. Ozacar (Izmir, Turkey)
Source:
Annual Congress 2006 - COPD – inflammation/miscellaneous
Session:
COPD – inflammation/miscellaneous
Session type:
E-Posters in free access
Number:
334
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Balci, S. Dereli, L. Usta, E. Tellioglu, Y. Vatansever, R. Ozacar (Izmir, Turkey). The cost analysis of our COPD patients. Eur Respir J 2006; 28: Suppl. 50, 334
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Related content which might interest you:
Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort
Source: International Congress 2017 – COPD: latest insights into the management of patients
Year: 2017
Direct cost analysis of COPD patients: A 1 year follow-up study
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Hospitalization cost analysis due to acute COPD exacerbations
Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system
Year: 2016
COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD
Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020
Year: 2021
A global survey conducted to determine frequency of exacerbations in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Care-continuity for COPD patients
Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences
Year: 2012
COPD patients
Source: Eur Respir Monogr 2021; 90: 154-164
Year: 2021
A retrospective cohort study demonstrating the impact of an OPEP device on exacerbations in COPD patients with chronic bronchitis
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Assessing the burden of repeated exacerbations among COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 64s
Year: 2004
The complexities of patients with COPD
Source: International Congress 2014 – Ceremony for the ERS Best Publication Maurizio Vignola Award for Innovation in Pneumology 2014 - Clinical Year in Review II
Year: 2014
Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study
Source: Eur Respir J 2010; 35: 532-539
Year: 2010
The cost of COPD: results from the SIRIBO study
Source: Eur Respir J 2002; 20: Suppl. 38, 125s
Year: 2002
COPD in elderly patients – an analysis of the DACCORD observational study
Source: International Congress 2018 – COPD around the world
Year: 2018
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Health care costs in COPD patients with severe respiratory failure: a prospective analysis
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
The costs of exacerbations in COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 273s
Year: 2001
Real life assessment of inhaler use and acute exacerbations in 2935 COPD patients
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept